Table 3.
In-person | Telehealth | Rate ratio (95% CI) | |
---|---|---|---|
Time in clinic (PY): | 167.4 | 153.08 | |
Primary Outcomes | |||
Tablets prescribed per PY (no.) Estimated medication possession (%) HIV screens per PY (no.) Creatinine tests per PY (no.) |
324.4 89 3.55 3.51 |
320.6 88 3.38 3.37 |
0.99(0.98-1.00) 0.95 (0.85–1.07) 0.96 (0.85–1.08) |
Secondary Outcomes | |||
Syphilis screens per PY (no.) CT/GC (urine) screens per PY (no.) CT/GC (pharyngeal) screens per PY (no.) CT/GC (rectal) screens per PY (no.) |
3.11 2.68 0.38 0.36 |
3.33 3.13 0.94 0.88 |
1.07 (0.95–1.21) 1.17 (1.03–1.33) 2.46 (1.83–3.30) 2.42 (1.79–3.27) |
Loss to Follow-up | |||
Clinic of most recent PrEP appointment (no.) Lost to follow up (no. [%]) |
40 12 (30) |
109 13 (11.9) |
Χ [2] (1, N = 149) = 6.85 P = 0.009 |
PY = Person-Year